Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 1063 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
ENDOCRINOLOGY AND GENDER
Year : 2020  |  Volume : 24  |  Issue : 2  |  Page : 128-135

IDEA group consensus statement on medical management of adult gender incongruent individuals seeking gender reaffirmation as female


1 Department of Endocrinology, KPC Medical College and Hospital, Kolkata, India
2 Department of Medicine, Vivekananda Institute of Medical Sciences, Kolkata, India
3 Department of Endocrinology, Institute of Post-Graduate Medical Education and Research, Kolkata, India
4 Department of Endocrinology, MS Ramaiah Memorial Hospital, Bengaluru, India
5 Department of Endocrinology, St. John's Medical College Hospital, Bengaluru, India
6 Department of Endocrinology, R. G. Kar Medical College and Hospital, Kolkata, West Bengal, India

Correspondence Address:
Anirban Majumder
GB, CHHAYANEER, 26 A, Gariahat Road, Kolkata - 700 031, West Bengal
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijem.IJEM_593_19

Rights and Permissions

Cross sex hormone therapy (CSHT) is a strongly desired medical intervention for gender incongruent individuals. The goal is to change secondary sex characteristics to facilitate gender presentation that is consistent with the desired sex. When appropriately prescribed CSHT can greatly improve mental health and quality of life for gender incongruent individuals. Appropriate care for gender incongruent individuals in India is almost absent due to lack of country specific guideline and lack of training amongst the medical professionals. This document is intended to assist endocrinologists and physicians whose adult gender incongruent client is seeking gender reaffirmation as female (transfeminine). These individuals require a safe and effective CSHT regimen that will suppress endogenous male hormone secretion and maintain physiologic levels of female sex hormone. In this document, we offer suggestions based on an in-depth review of Guidelines of Endocrine Society, The World Professional Association for Transgender Health guidelines, the Sappho Good Practice Guide of India and collegial meetings with expert Indian clinicians working in this field. Clinicians represented in our expert panel are not gender specialists by training but have developed expertise due to the volume of gender incongruent individuals they manage. This consensus statement on medical management provides protocols for the prescribing clinician relating to diagnosis, baseline evaluation and counselling, prescription planning for feminizing hormone therapy and anti-androgen therapy, targets for monitoring hormone therapy, choice of therapy, clinical and biochemical monitoring, recommending sex reaffirmation surgery and peri-operative hormone therapy. The recommendations made in this document should not be perceived as a rigid set of guidelines and the treating clinicians are encouraged to modify our suggested protocols to address emerging issues.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed778    
    Printed17    
    Emailed0    
    PDF Downloaded190    
    Comments [Add]    

Recommend this journal